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Abstract
The periodontal pathogen Actinobacillus actinomycetemcomitans expresses a cytolethal distending
toxin (CDT) that typically arrests the growth of eukaryotic cells at either the G0/G1 or G2/M phase
of the cell cycle. It was previously found that CDT failed to arrest the growth of human periodontal
ligament fibroblasts (HPLFs) when grown in pure culture. In contrast, proliferation of an oral
epithelial cell line was rapidly inhibited by the toxin. In this study, the feasibility of using mixed-
cell cultures and cell-specific markers to evaluate the response of oral cells, when in heterogeneous
populations, to CDT was established. Proliferation of epithelial cells was rapidly inhibited and the
cells were selectively eliminated in co-culture with HPLFs or cementoblasts by 24–48 h post-
intoxication. Epithelial cells and HPLFs were detected and counted in co-cultures following cell-
specific immunolabelling with antibodies against simian virus 40 large T antigen and the Ab-1 surface
antigen, respectively. These results demonstrated that the activities of potential virulence factors,
such as CDT, from periodontal pathogens can be successfully examined in mixed-cell cultures. This
approach is especially relevant to infectious diseases that affect tissues with a diverse cellular
composition, such as the periodontium.
INTRODUCTION
Cytolethal distending toxin (CDT) of Actinobacillus actinomycetemcomitans is a secreted
protein toxin that inhibits the proliferation of a wide variety of cell types and cell lines. The
holotoxin from this bacterium is assembled from the products of three genes (cdtA, cdtB and
cdtC) that have homologues in at least five other pathogenic Gram-negative bacterial genera
(Sugai et al., 1998; Mayer et al., 1999; Mao & DiRienzo, 2002). Eukaryotic cells that are
sensitive to the toxin are usually arrested at the G0/G1 or G2/M phase of the growth cycle
(Comayras et al., 1997; Whitehouse et al., 1998; Cortes-Bratti et al., 1999; Shenker et al.,
1999). CDT triggers the block in cell-cycle progression through the action of a DNase I-like
nuclease (CdtB) that causes double-strand breaks in the host-cell DNA (Elwell & Dreyfus,
2000; Lara-Tejero & Galán, 2000; Cortes-Bratti et al., 2001; Frisan et al., 2003; Hassane et al.,
2003).
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A. actinomycetemcomitans is a facultative, Gram-negative bacterium that has long been
associated with localized aggressive periodontitis. A. actinomycetemcomitans is one of the few
periodontal pathogens capable of active tissue invasion (Blix et al., 1992; Meyer et al., 1996).
The bacterium expresses a number of gene products that can be defined as virulence factors
based on their in vitro biological activities or similarities to products produced by other
pathogens (Henderson et al., 2003). Although CDT is not unique to A.
actinomycetemcomitans, this bacterium is the only member of the oral microbial flora
identified to date that carries and expresses the toxin locus (Yamano et al., 2003). CDT is
prevalent in A. actinomycetemcomitans strains. Ahmed et al. (2001) found that 43 of 50 strains
from periodontitis patients contained all three cdt genes and expressed CDT activity. In another
study, PCR of subgingival plaque samples revealed that 13 of 106 diseased sites in 146 patients
with aggressive and chronic periodontitis contained A. actinomycetemcomitans expressing all
three cdt genes (Tan et al., 2002). Fabris et al. (2002) reported that 39 of 40 A.
actinomycetemcomitans isolates from a mix of healthy and periodontal diseased subjects
expressed activity that caused the distension of CHO cells.
We were interested in characterizing the biological effects of A. actinomycetemcomitans CDT
on cells of the human periodontium. If this toxin has a primary role in periodontal disease, it
most likely occurs through interactions with the various cellular components of the
periodontium including fibroblasts, epithelial cells and cementoblasts. In conjunction with
other resident cell types, these cells are responsible for maintaining the structural integrity of
the periodontium, as well as facilitating the repair and/or regeneration of these tissues following
injury (Lekic et al., 1997). We recently showed that fibroblasts derived from human periodontal
ligament (HPLFs) did not display growth inhibition, cell-cycle arrest or dsDNA damage
typically associated with CDT (Kanno et al., 2005). In contrast, a human oral epithelial cell
line, GMSM-K, was exquisitely sensitive to the toxin. The differential responses of these
various cell types to CDT has important implications for the initial colonization of the
periodontium by A. actinomycetemcomitans, as well as the health and remodelling of
periodontal tissues. The ability of CDT to inhibit the growth of oral epithelial cells may lead
to disruption of the protective barrier formed by these cells, facilitating invasion and
perturbation of the underlying connective tissue.
In this study, we examined the ability of CDT specifically to inhibit the proliferation of oral
epithelial cells when grown in co-culture with HPLFs and cementoblasts. We have shown that
cell-specific markers can be used to identify and quantify distinct cell types in CDT-treated
co-cultures. The potential application of this novel approach to the characterization of virulence
factors of periodontal pathogens is discussed.
METHODS
Cells and tissue-culture conditions. An immortalized human oral epithelial cell line, GMSM-
K, was obtained from Valerie Murrah of the Department of Diagnostic Sciences and General
Dentistry, University of North Carolina at Chapel Hill, USA. This cell line was used because
attempts to isolate and maintain pure primary cultures of human gingival epithelial cells were
inconsistent. Cells were routinely grown in T-75 flasks in keratinocyte serum-free medium
(Invitrogen) as reported previously (Kanno et al., 2005; Gilchrist et al., 2000). Cells were
passaged in modified Eagle's medium (Medium 199; Gibco), containing 10 % fetal calf serum
(FCS), antibiotics (10 000 U penicillin G ml−1, 25 μg streptomycin ml−1) and an antimycotic
(0·85 % fungizone). Cells were passaged in Medium 199 twice prior to use in co-culture
experiments. Cultures were examined by light microscopy to confirm growth based on an
increase in cell number. The growth medium was changed every 3 days until the cells were
approximately 80 % confluent. At that time, cells were detached from the plates by treatment
with trypsin (1 mg ml−1 in PBS) for 10 min followed by treatment with soybean trypsin inhibitor
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(2 mg ml−1 in PBS; Sigma). Detached cells were collected by centrifugation, washed twice
with Ca2+/Mg2+-free PBS and suspended in 10 ml fresh medium for use in co-culture
experiments.
HPLFs were derived from periodontal ligament explants using a technique similar to that
described by Somerman et al. (1988). Clinically healthy premolars and third molars were
obtained from five patients (three males and two females with ages ranging from 23 to 28 years)
who presented to the Oral Surgery Clinic of the University of Pennsylvania School of Dental
Medicine. Immediately following extraction, the teeth were placed into Medium 199
supplemented with penicillin G (10 000 U ml−1), streptomycin (25 μg ml−1) and fungizone
(0·85 %). Within 1 h of extraction, the teeth were washed twice with fresh medium and the
attached gingival tissue removed. The teeth were then placed in a Petri dish containing medium
and the periodontal ligament dissected away from the mid-third of the root surface by gentle
scraping with a disposable surgical scalpel.
The collected tissue was centrifuged at 1000 r.p.m. for 10 min at 4 °C. The tissue was suspended
in 5 ml growth medium supplemented with 10 % FCS and incubated at 37 °C in 5 % CO2.
Monolayers of HPLFs were typically observed 2–3 weeks after the initial seeding of cultures.
Upon reaching confluence, the primary cultures were treated with trypsin (2·5 mg ml−1 in PBS)
to detach the cells for passage. Cells were stored in 2 ml 10 % (v/v) DMSO in Medium 199 in
liquid nitrogen. For growth experiments, the medium was changed every 3 days until cells
were approximately 80 % confluent. Cells were detached from the plates as described for the
epithelial cells except that 2·5 mg trypsin ml−1 was used. The detached cells were then placed
immediately into 5 ml fresh growth medium containing FCS for use in the co-culture
experiments.
Primary human cementoblasts (C11-26M) were maintained in alpha minimal essential medium
supplemented with 10 % FCS and antibiotics as described previously (Grzesik et al., 1998,
2000). Cementoblasts were grown in T-75 flasks in Medium 199 and an increase in cell number
was confirmed using light microscopy. The growth medium was changed every 3 days until
the cells were approximately 80 % confluent. At that time, cells were detached from the plates
as described for HPLFs. Detached cells were collected by centrifugation and suspended in 10
ml fresh medium for use in the co-culture experiments.
All protocols for obtaining and handling human oral tissues were reviewed and approved by
the Institutional Review Board of the University of Pennsylvania.
Bacterial strains, growth conditions and preparation of CDT. A recombinant clone
containing the A. actinomycetemcomitans cdt locus, E. coli BL21(DE3)(pET15bcdt), has been
constructed and characterized previously (Mao & DiRienzo, 2002). For preparation of CDT-
containing extracts, the recombinant clone was grown in Luria–Bertani medium containing
100 μg ampicillin ml−1 at 37 °C with vigorous shaking. Late exponential-phase cultures
(OD600 0·8–1·0) were treated with IPTG (Fisher Scientific) at a final concentration of 1 mM
and the cultures were incubated for an additional 4–5 h. Bacteria were harvested by
centrifugation, washed twice with PBS and suspended in PBS. Bacteria were disrupted by
sonication in an ice bath using three 30 s pulses each separated by a 30 s rest (Braun-Sonic
2000; B. Braun Biotech). The preparations were centrifuged at 12 000 g for 10 min (Spinco
model SS-34 rotor) to remove unbroken cells and sterilized by passage through a 0·45 μm pore
size filter (Millipore). Total protein was determined with the Micro BCA Protein Assay kit
(Pierce Biotechnology). The toxic dose (TD)50 concentration (at which 50 % of the cell
population is killed) was determined as described previously (Mayer et al., 1999). Expression
of cdt genes was verified by analysis of total cell protein using 10–20 % polyacrylamide Tris/
HCl Ready Gels (Bio-Rad Laboratories) as described previously (Kanno et al., 2005).
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Light microscopy. For mixed cultures of epithelial cells and either HPLFs or cementoblasts,
cells were detached from plates and suspended in fresh Medium 199 supplemented with 10 %
FCS. Cell suspensions were adjusted so that 6 × 104 GMSM-K cells were added to each of two
T-25 flasks. An equivalent number of HPLFs or cementoblasts was added to each of the
epithelial-cell cultures. Both flasks of each set of co-cultures (GMSM-K/HPLFs and GMSM-
K/cementoblasts) were incubated for 24 h at 37 °C in an atmosphere containing 5 % CO2. After
24 h, a TD50 equivalent of filter-sterilized CDT-containing extract [4·5 μg total protein (ml
medium)−1] from E. coli BL21(DE3)(pET15bcdt) was added to one culture flask of each set.
The second flask of each set did not receive toxin and served as a control. The cultures were
incubated for up to 72 h post-intoxication. Digital photographs of both the control and the
CDT-treated cultures were taken at 0, 24, 48 and 72 h post-intoxication using a Nikon TMS-
F inverted microscope and a Fuji Finepix S-2 camera.
Cell-cycle analysis. Cell-cycle arrest was determined by flow cytometry as described
previously (Kanno et al., 2005). Cementoblast (C11-26M) cultures (1 × 106 cells) were
untreated or treated with total soluble protein from E. coli BL21(DE3)(pET15bcdt) at a
concentration of 18·4 μg (ml medium)−1. Cultures were incubated for up to 72 h post-
intoxication. Nuclei from washed cells were isolated and stained with propidium iodide (Sigma
Chemicals) by a standard procedure (Vindelov, 1977) as described previously (Kanno et al.,
2005). Stained nuclei were analysed on a FACSCalibur flow cytometer at the University of
Pennsylvania Cancer Center Flow Cytometry and Cell Sorting Shared Resource Facility. Data
from 30 000 events were analysed using ModFit 3.0 (Verity Software House).
PFGE. Cementoblast cultures (5 × 106 cells) were incubated overnight. One culture received
a TD50 equivalent dose of total soluble protein from E. coli BL21(DE3)(pET15bcdt) at a
concentration of 4·5 μg (ml medium)−1. A second culture did not receive any extract. Cells
were collected after incubation for 72 h post-intoxication and prepared for analysis by
electrophoresis as described previously (Kanno et al., 2005). Electrophoresis was performed
at 175 V (starting voltage) for 40 h at 4 °C.
Validation of cell-specific markers. GMSM-K cells (1·5 × 104 cells per well), HPLFs (1·0 ×
104 cells per well) and cementoblasts (1·0 × 104 cells per well) were grown separately in
Medium 199 in eight-well chamber slides (Nalgene Nunc International). Slides were incubated
for 24 h at 37 °C in a moist atmosphere containing 5 % CO2. Cells were washed twice with
cold PBS, fixed in 10 % formalin for 10 min at room temperature and made permeable with
0·2 % Triton X-100 in PBS (pH 7·0). Slides were washed three times with PBS and then treated
with 200 μl 1 % BSA in PBS per well as a blocking buffer for 30 min at room temperature.
Slides were washed twice with PBS and each well of one set of wells containing either HPLFs,
GMSM-K cells or cementoblasts was incubated with 200 μl fibroblast antigen (Ab-1; Oncogen
Research Products) or anti-cytokeratin mAb (AE1; Zymed Laboratories) at a 1 : 200 dilution
in 1 % BSA/PBS for 1 h at room temperature. Unbound antibody was removed by washing
the slides three times with PBS. Two hundred microlitres of a 1 : 1000 dilution of Alexa Fluor
488 goat anti-mouse IgG (heavy and light chain) conjugate (Molecular Probes) in 1 % BSA/
PBS was then added to each well and the slides incubated for 30 min in the dark. Wells
containing GMSM-K cells were also counterlabelled with the DNA-binding fluorochrome 4,6-
diamidino-2-phenylindole (DAPI) at a concentration of 1 μg (ml mounting solution)−1. Three
other sets of wells containing either HPLFs, GMSM-K cells or cementoblasts were treated with
200 μl per well of a 1 : 200 dilution of mouse anti-simian virus 40 (SV40) T-antigen mAb
(Chemicon International) and a 1 : 1000 dilution of Alexa Fluor 488 goat anti-mouse IgG in 1
% BSA/PBS. Slides were stored in the dark for 30 min at room temperature. HPLFs and
cementoblasts were also counterlabelled with Texas red-X–phalloidin (Molecular Probes)
using a 1 : 1000 dilution.
Kang et al. Page 4
J Med Microbiol. Author manuscript; available in PMC 2006 August 1.
Slides were washed with PBS, dried at room temperature and treated with one drop of mounting
solution (Prolong Anti-Fade; Promega). Cover slips were placed on the slides and viewed under
a Nikon Eclipse E600 fluorescence microscope with filters FITC-HYQ for Alexa Fluor 488
conjugate (excitation wavelengths 460–500 nm), Texas red-HYQ (excitation wavelengths
532–587 nm) and UV-2E/C-DAPI (excitation wavelengths 330–380 nm). Images were
captured by filtering for individual fluorochromes and then digitally overlaid.
Immunofluorescent detection of CDT-treated cells. GMSM-K cells (1·5 × 104 cells per well)
and HPLFs (1·0 × 104 cells per well) were mixed in Medium 199 in eight-well chamber slides.
Slides were incubated for 24 h at 37 °C in a moist atmosphere containing 5 % CO2. The growth
medium was then removed and cells were incubated with 200 μl protein extract from E. coli
BL21(DE3)(pET15bcdt) at a final concentration of 15 μg (ml medium)−1. Cells incubated with
diluted extract from E. coli BL21(DE3)(pET15b) were used as controls. In some experiments,
slides were incubated for 24, 48 and 72 h post-intoxication without removal of excess toxin
(continuous exposure). In other experiments, slides were incubated with toxin-containing
extract for 15 min, after which the cells were washed and incubated in fresh medium for 0, 3,
6, 24 and 48 h post-intoxication. At the end of the incubation periods, cells were washed twice
with cold PBS, fixed and made permeable as described above. Slides were washed three times
with PBS and then treated with 200 μl 1 % BSA/PBS blocking buffer per well for 30 min at
room temperature. Slides were washed twice with PBS and incubated with 200 μl Ab-1 mAb
per well at a 1 : 200 dilution in 1 % BSA/PBS for 1 h at room temperature. Unbound antibody
was removed by washing the slides three times with PBS. Two hundred microlitres of a 1 :
1000 dilution of Alexa Fluor 488 goat anti-mouse IgG conjugate in 1 % BSA/PBS was then
added to each well and the slides incubated for 30 min in the dark. Slides were washed with
PBS followed by 200 μl of a 1 : 200 dilution of anti-SV40 T-antigen biotin-labelled mAb (BD
Biosciences-Pharmingen) per well diluted in 1 % BSA/PBS. Slides were stored in the dark for
1 h at room temperature, washed three times with PBS and incubated with a 1 : 1000 dilution
of streptavidin conjugated to Texas red-X (Molecular Probes) in 1 % BSA/PBS at room
temperature for 30 min. Finally, slides were washed with PBS, dried at room temperature and
mounted with coverslips.
Co-cultures of epithelial cells and cementoblasts were treated similarly. GMSM-K cells (1·5
× 104 cells per well) and C11-26M cells (1·0 × 104 cells per well) were suspended in Medium
199 and added to each well of an eight-well chamber slide. Cultures were incubated for 24 h
at 37 °C in a moist atmosphere containing 5 % CO2 and prepared as described for the epithelial
cell/HPLF co-cultures. Cells were made permeable and incubated with 200 μl of a 1 : 200
dilution of anti-SV40 T-antigen mAb in 1 % BSA/PBS per well in the dark for 1 h at room
temperature. The secondary antibody was a 1 : 1000 dilution of Alexa Fluor 488 goat anti-
mouse IgG in 1 % BSA/PBS. Slide cultures were also stained for F-actin at room temperature
for 30 min with Texas red-X–phalloidin diluted 1 : 1000.
Slides containing CDT-treated HPLFs (1·0 × 104 cells per well) and cementoblasts (C11-26M;
1·0 × 104 cells per well) were treated with a 1 : 200 dilution of Ab-1 mAb, a 1 : 1000 dilution
of Alexa Fluor 488 goat anti-mouse IgG and a 1 : 1000 dilution of Texas red-X–phalloidin.
Images were captured by filtering for individual fluorochromes and then digitally overlaid.
RESULTS
Microscopic evaluation of CDT-treated human oral cells grown in co-culture
Equivalent cell numbers of GMSM-K cells and HPLFs were seeded in duplicate cultures. One
set of cultures was left untreated and the other set was treated with recombinant CDT-
containing bacterial extract. Growth of both sets of cultures was documented at 0, 24, 48 and
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72 h of growth post-intoxication by bright-field microscopy. Both types of cells were present
and increased in cell number through 72 h of growth in the untreated cultures (Fig. 1, left
column). By 24 h, the HPLFs had begun to overgrow the GMSM-K cells in the CDT-treated
cultures (Fig. 1, right column). After 72 h of growth, no epithelial cells were observed,
especially after the cultures had been washed to remove non-adherent cells (Fig. 1, inset in
lower right panel). Identical results were obtained when GMSM-K cells were grown in co-
culture with cementoblasts (data not shown). In this case, cementoblasts predominated the
cultures at 72 h post-intoxication.
Resistance of cementoblasts to CDT was confirmed by flow cytometry at 48 and 72 h post-
intoxication (Fig. 2). Eighty-three per cent of the cells had a DNA content of 2n (G0/G1) and
0 % had a content of 4n (G2/M) after exposure to recombinant CDT-containing bacterial extract
for 72 h, indicative of no cell-cycle arrest. Cementoblast cultures exposed to the CDT-
containing extract for 72 h also showed no signs of DNA damage. All of the DNA remained
in the well after PFGE (Fig. 2, inset).
Identification and validation of cell-specific markers
The simple microscopic evaluation of CDT-treated cells in co-culture gave a clear indication
of the differential effects of the toxin. However, the availability of cell-specific markers
provides a more definitive method for tracking changes in mixed-cell populations. Fibroblasts
express a cell-surface antigen, Thy-1 (CD90), that is a potential candidate for a specific marker
(Saalbach et al., 1996, 1999). Since the GMSM-K cell line is virally transformed, the cells
express the SV40 large T antigen (Gilchrist et al., 2000). To determine the specificity of these
potential cell markers, HPLFs and GMSM-K cells were grown separately in culture and
immunolabelled using commercially available primary antibodies against each of these
proteins (Fig. 3). When HPLFs and GMSM-K cells were individually labelled with anti-Ab-1
mAb and Alexa Fluor 488-conjugated secondary antibody, only HPLFs were detected (Fig. 3,
left column). Counter-staining the GMSM-K cultures with DAPI showed that cells were
present but not recognized by the Ab-1 mAb. A mouse anti-cytokeratin mAb (AE1) was also
tested for specific recognition of HPLFs. However, this antibody preparation yielded poor
results in immunofluorescence experiments (data not shown). Opposite results were obtained
with mouse anti-SV40 T-antigen mAb and Alexa Fluor 488-conjugated secondary antibody
(Fig. 3, right column). Counterstaining the HPLFs with Texas red-X–phalloidin demonstrated
that the cells were present but not recognized by the SV40 T-antigen antibodies. These results
established that specific markers could be used to distinguish epithelial cells from fibroblasts
when grown in co-culture. These antibodies failed to recognize cementoblasts; currently no
specific markers have been identified for this cell type.
Use of specific immunofluorescence tagging to confirm the differential effects of CDT on the
growth of human oral cells in mixed cultures
The specific T-antigen and Thy-1 markers were used to evaluate the effects of CDT on mixed
cultures. GMSM-K cells and HPLFs were co-grown and examined at 24 h post-intoxication
with CDT. HPLFs were labelled with Ab-1 mAb and Alexa Fluor 488 goat anti-mouse IgG
conjugate (green fluorescence). GMSM-K cells were labelled with SV40 T-antigen biotin-
labelled mAb and streptavidin–Texas red-X conjugate (red fluorescence). No epithelial cells
were detected in co-labelled mixed cultures that were treated with CDT (Fig. 4, upper right
panel). These data confirmed the results initially obtained using light microscopy. The same
results were obtained with mixed cultures of GMSM-K cells and cementoblasts (Fig. 4, middle
row). In this case, the epithelial cells were tagged with mouse anti-SV40 large T-antigen mAb
and Alexa Fluor 488 goat anti-mouse IgG conjugate (green fluorescence). The cementoblasts
were non-specifically stained with Texas red-X–phalloidin (red fluorescence). As expected,
there was no effect of CDT on mixed cultures of HPLFs and cementoblasts (Fig. 4, lower row).
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The HPLFs were tagged with Ab-1 mAb and Alexa Fluor 488 goat anti-mouse IgG conjugate
(green fluorescence) and the cementoblasts were stained with Texas red-X–phalloidin. Images
captured by filtering for the individual fluorochromes (insets) are shown for all panels.
When co-cultures of GMSM-K cells and HPLFs were treated with toxin and observed over
time, a clear pattern of epithelial-cell inhibition was observed. An increase in epithelial-cell
number was evident in untreated co-cultures up to 72 h post-intoxication (Fig. 5, left column).
Inhibition of epithelial cell proliferation was observed in CDT-treated co-cultures (Fig. 5, right
column). Epithelial cells were eradicated between 24 and 48 h of growth. Elimination of
epithelial cells in co-cultures was relatively rapid, even after a short exposure (15 min) to toxin.
No epithelial cells were observed after 24 h of growth post-intoxication, as was the case with
long-term exposure (data not shown).
DISCUSSION
A. actinomycetemcomitans is a well-studied, periodontal pathogen that produces an impressive
array of potential virulence factors including toxins such as leukotoxin and CDT (Henderson
et al., 2003). It has been a challenge to prove that these toxins play an active role in disease.
We were interested in the role of CDT in the virulence potential of A.
actinomycetemcomitans and its possible contribution to periodontal disease. Although it has
not yet been experimentally established that CDT is involved in periodontal disease, prevalence
of the cdt locus in clinical isolates of the bacterium and the unusual cytotoxic properties of
CDT indirectly support the argument that the toxin is potentially an important virulence factor.
There is also evidence, from DNA sequence analysis of chromosomal regions that flank the
cdt locus, that the cdt genes may have been acquired by A. actinomycetemcomitans via
horizontal gene transfer (Mayer et al., 1999; Heywood et al., 2005). Taken together, these
observations support the concept that there is environmental pressure on the bacterium in the
human oral cavity to maintain and express the cdt genes. It is expected that the cdt locus would
have been eliminated from the A. actinomycetemcomitans population if it did not impart some
advantage to the bacterium in the periodontium.
The periodontium is composed of a number of distinct cell types including epithelial cells,
fibroblasts, cementoblasts and osteoblasts, amongst others (Hassel, 1993). From a functional
standpoint, the periodontium can be broadly broken down into two tissue compartments
referred to as gingiva and the attachment apparatus. Gingiva, which is composed of epithelial
cells and the adjacent connective tissue, is attached to a tooth via hemidesmosomes formed by
cells of the junctional epithelium. This provides a physical barrier that protects the underlying
attachment apparatus from the potentially harmful host as well as microbial and/or
environmental factors found within the oral cavity proper. In view of the diverse cellular make-
up of the periodontium, we recently examined the response of oral epithelial cells and HPLFs
to CDT produced by A. actinomycetemcomitans. We found that CDT selectively inhibited the
proliferation of human oral epithelial cells, while HPLFs were resistant to the classical activities
characteristic of this family of toxins (Kanno et al., 2005). HPLFs challenged with CDT in
culture did not arrest at either the G0/G1 or G2/M phase of the cell cycle, nor did they exhibit
dsDNA damage. It was previously reported that CDT of A. actinomycetemcomitans is involved
in the non-lethal inhibition of proliferation of HPLFs and human gingival fibroblasts
(Belibasakis et al., 2002). More recently it was suggested that inhibition was associated with
cell-cycle arrest at both the G0/G1 and G2/M phases of growth (Belibasakis et al., 2004).
However, these effects were not observed using either crude extracts or purified recombinant
A. actinomycetemcomitans CDT in our studies (Kanno et al., 2005). In contrast, proliferation
of human epithelial cell lines was rapidly inhibited by CDT (Akifusa et al., 2001; DiRienzo et
al., 2002; Kanno et al., 2005). Growth arrest of the human oral epithelial cells occurred at the
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S phase of the cell cycle, indicative of a block in DNA replication, and was accompanied by
extensive dsDNA damage (Kanno et al., 2005).
Studies of the effects of A. actinomycetemcomitans CDT on human oral cells described above
were done using pure cultures. While this approach is a required first step in elucidating the
complex biological mechanisms of a microbial toxin, it is a somewhat artificial system,
especially when considering an environment as complex as the human periodontium. The
interaction of cells and cell products can affect or alter the activities of microbial factors. For
example, microbial factors can adhere to cells or cell products, rendering the factor inactive or
unavailable to other cells. In an attempt to address some of these issues, we evaluated the
feasibility of using mixed cultures for examining the response of oral cells to A.
actinomycetemcomitans CDT.
Co-cultures of oral cells have been used to evaluate the irritancy of dental materials (Schmalz
et al., 1997), expression of growth factors (Gron et al., 2002) and the effects of cancer cells on
normal cells (Sawaki et al., 2003). However, to the best of our knowledge, the cell-specific
effects of bacterial toxins have not been examined in co-culture systems. Our earlier finding
that there was a differential response of the oral epithelial cells and HPLFs to CDT provided
a testable co-culture model.
We first successfully established that there was no cross inhibition of growth or overgrowth
of one cell type when the epithelial cells and fibroblasts or epithelial cells and cementoblasts
were grown in co-culture. Cementoblasts showed the same response to CDT as HPLFs when
grown as pure cultures and this response seems to be typical of oral fibroblast-like cells.
Secondly, it was necessary to identify and validate cell-specific markers for the simultaneous
detection of each cell type in co-cultures. An SV40 T-antigen mAb was used specifically to
detect the GMSM-K cell line. This cell line is immortalized by SV40 transfection and expresses
the SV40 large T antigen (Gilchrist et al., 2000). It was found that a mAb against the human
Thy-1 (CD90) antigen was specific for the fibroblasts (Saalbach et al., 1996). This antigen is
a 35 kDa glycoprotein found on the extracellular membrane of fibroblasts, neurons and some
CD34+ blood stem cells (Saalbach et al., 1999). A cementoblast-specific marker was not
identified.
Using this approach, we clearly demonstrated that the epithelial cells increased in number
during co-growth with HPLFs. However, proliferation of the epithelial cells was selectively
and rapidly inhibited by CDT in co-culture with either HPLFs or cementoblasts. This selective
inhibition was readily observed by light microscopy of CDT-treated co-cultures and confirmed
by immunofluorescence microscopy. No epithelial cells were detected by 24 h post-
intoxication in co-cultures exposed to CDT for relatively short times (15 min). These results
demonstrated that the response of epithelial cells, fibroblasts and cementoblasts to CDT was
the same whether the cells were cultured separately or together.
The ability to measure the response of individual cell types to bacterial toxins in mixed cultures
has important applications in the study of the pathogenesis of periodontal disease. In the context
of pathogenesis, the differential responses of the various cell types observed in mixed-cell
culture suggest that, in vivo, CDT has the potential to compromise the integrity of gingival
epithelium, allowing the organism and/or virulence factors to gain access to the underlying
connective tissue. Furthermore, there may be indirect effects of CDT that are mediated via the
release of molecules derived from dying and/or dead epithelial cells that could have detrimental
effects on the other types of cells within the periodontium. This is a testable hypothesis in
vitro using mixed cultures. The results of this study suggest that this does not occur with respect
to HPLFs and cementoblast proliferation. This does not rule out the possibility of altered
cellular function, which will be addressed in future studies. Along these lines, it will be
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interesting to examine the expression of inflammatory mediators and other factors known to
have key roles in advancing the degradation of the various components of the periodontium.
It has been reported that CDT of A. actinomycetemcomitans regulates the expression of receptor
activator of NF-κB ligand (RANKL) and osteoprotegerin by periodontal ligament cells
(Belibasakis et al., 2005). Since expression of these molecules is involved in osteoclast
differentiation, they have a central role in the regulation of bone resorption, a key component
of periodontitis (Liu et al., 2003; Mogi et al., 2004).
In summary, we have (i) demonstrated that HPLFs, cementoblasts and human oral epithelial
cells can be grown together in culture; (ii) established the utility of using specific markers for
the simultaneous detection of several of these oral cell types in mixed cultures; and (iii) used
these markers to demonstrate that the same cell-specific responses to CDT identified in pure
cultures could be observed in heterogeneous cell populations. The approach described in this
study will be useful for advancing studies of more complex interactions between microbial
virulence factors and those cells targeted in periodontitis.
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Fig. 1.
Microscopic evaluation of the effects of CDT on HPLFs and oral epithelial cells (GMSM-K)
grown in co-culture. Two sets of cell cultures were grown overnight in Medium 199. One set
was left undisturbed (−CDT), while CDT-containing extract from E. coli BL21(DE3)
(pET15bcdt) at a concentration of 0.9 mg protein (200 ml medium)−1 was added to the second
set (+CDT). The cultures were examined microscopically after incubation for an additional 0,
24, 48 and 72 h. At the end of the experiment, the 72 h cultures were washed to remove dead
cells and re-examined (insets). Images are representative of multiple microscopic fields
examined. Magnification × 10.
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Fig. 2.
Examination of CDT-treated cementoblasts for cell-cycle arrest and dsDNA damage.
Cementoblast cultures (1 × 106 cells) were left untreated (a) or were treated (b, c) with medium
containing protein extract from E. coli BL21(DE3)(pET15bcdt) at a concentration of 18.4 μg
ml−1. Cell nuclei were collected and stained at 48 h (b) and 72 h (c) post-intoxication. Cell-
cycle profiles obtained by flow cytometry are shown. The DNA profile determined by
propidium iodide staining is shown as the open tracing marked PI. G0/G1 and G2/M (filled)
and S (hatched) peaks were determined by computer analysis. The percentages of cells in the
population in the diploid G1, diploid G2 and diploid S states are shown. CV is the coefficient
of variance. The insets show PFGE of untreated and CDT-treated (72 h) cultures. Gels were
stained with ethidium bromide. The position of the wells in the agarose gel is marked.
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Fig. 3.
Validation of cell-specific markers for HPLFs and GMSM-K cells. HPLFs and GMSM-K cells
were grown separately in Medium 199 for 24 h on chamber slides. Slides were treated with
either Ab-1 or mouse anti-SV40 T-antigen mAb (diluted 1 : 1000) followed by Alexa Fluor
488 goat anti-mouse IgG (diluted 1 : 1000). GMSM-K cells that were treated with Ab-1 mAb
were also labelled with DAPI (GMSM-K inset). HPLFs that were treated with SV40 T-antigen
mAb were also labelled with Texas red-X– phalloidin (HPLF inset). All slides were examined
using a fluorescence microscope and images recorded with a digital camera. Magnification
×60.
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Fig. 4.
Use of immunospecific staining to determine the effects of CDT on proliferation of oral cells
grown in co-culture. GMSM-K cells, HPLFs and cementoblasts (C11-26M) were grown in
pairs for 24 h on chamber slides. The paired cultures were either untreated (left column) or
treated with CDT (right column). GMSM-K/HPLF co-cultures were labelled with anti-SV40
T-antigen biotin-labelled mAb and streptavidin conjugated to Texas red-X (red fluorescence)
and with Ab-1 and Alexa Fluor 488 goat anti-mouse IgG conjugate (green fluorescence).
GMSM-K/C11-26M co-cultures were labelled with anti-SV40 T-antigen mAb and Alexa Fluor
488 conjugate (green fluorescence) and Texas red-X–phalloidin (red fluorescence). HPLF/
C11-26M co-cultures were labelled with Ab-1 and Alexa Fluor 488 conjugate (green
fluorescence) and Texas red-X–phalloidin (red fluorescence). Arrows mark the positions of
labelled GMSM-K cells. Insets show fluorescence of the individual fluorochromes. Images are
representative of multiple microscopic fields examined. Magnification ×60.
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Fig. 5.
Time course of untreated and CDT-treated co-cultures of HPLFs and oral epithelial cells.
HPLFs and GMSM-K cells were grown for 24 h on chamber slides and left untreated (left
column) or treated with CDT (right column). Cultures were incubated and examined at 24, 48
and 72 h post-intoxication. Co-cultures were labelled with anti-SV40 T-antigen biotin-labelled
mAb and streptavidin–Texas red-X (red fluorescence), and Ab-1 and Alexa Fluor 488
conjugate (green fluorescence). The arrow marks the position of a labelled GMSM-K cell in
a CDT-treated co-culture. Immunofluorescence of the individual fluorochromes is shown in
the insets in the lower left panel. Images are representative of multiple microscopic fields
examined. Magnification ×60.
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